Dabigatran etexilate: future directions in anticoagulant treatment. - Wikidata - wikimedia - TriplyDB

Dabigatran etexilate: future directions in anticoagulant treatment.

Dabigatran etexilate: future directions in anticoagulant treatment.

http://www.wikidata.org/entity/Q37579455

about

Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?

P2860

Q34611004-6EB1D50C-32B9-4B50-B46B-748DFB625147 Q43286263-99E16E2D-913D-473F-A357-0FB881B98F2A

P2860

Dabigatran etexilate: future directions in anticoagulant treatment.

http://www.wikidata.org/entity/Q37579455

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dabigatran etexilate: future directions in anticoagulant treatment.

@en

Dabigatran etexilate: future directions in anticoagulant treatment.

@nl

type

label

Dabigatran etexilate: future directions in anticoagulant treatment.

@en

Dabigatran etexilate: future directions in anticoagulant treatment.

@nl

prefLabel

Dabigatran etexilate: future directions in anticoagulant treatment.

@en

Dabigatran etexilate: future directions in anticoagulant treatment.

@nl

P1433

Q37579455-127D0EE9-A930-4787-B93D-A169C3174C3C

P1476

Q37579455-CE2C1349-A4F6-42F8-B582-3A8D64778EBA

P2093

Q37579455-AA246819-6173-4393-B050-630D98BDD5E0

P2860

Q37579455-01E8ED68-C63A-487C-A016-951A9E74A255

Q37579455-02C52977-5AF2-420E-AA35-48187D2EA871

Q37579455-0FC71986-A9C9-4391-9A37-7B1497252E13

Q37579455-1A66BC87-1E66-4C7F-BCF2-7323B694EBD6

Q37579455-24BAB56A-47B5-4065-92D6-105096326861

Q37579455-2B18E726-87B1-40B5-8A4E-9DB07B960193

Q37579455-304D811D-666D-4883-B547-9ADB5D8DF802

Q37579455-3312A7E4-4022-4BD0-9D2A-77E891965773

Q37579455-36A79988-3D85-4F00-A4A6-9492D1DD0E0E

Q37579455-3B224DE8-1270-4E67-ADC7-CA51CABB5681

P304

Q37579455-D898B09A-B922-44E3-89BA-1F5A576CA7CA

P31

Q37579455-CA8B1F70-0D4B-438E-8915-0EDE0CA2BD4C

P356

Q37579455-40390BAD-6A14-41E2-A46F-9D69E4DA986E

P478

Q37579455-8F19515D-8994-4E19-BF6A-62821D2D58D8

P50

Q37579455-94E030AB-11D3-471B-A9C6-E406021F92B4

P577

Q37579455-748D1A3D-00BF-4A86-A55A-F3F4A6289E1A

P698

Q37579455-1FEF5081-BD55-45C3-92A7-E21F05D95A5A

P921

Q37579455-A5A5B871-388F-4CE1-A16D-EC4523B4A3A3

P356

1076029609344199

P1433

Clinical and Applied Thrombosis-Hemostasis

P1476

Dabigatran etexilate: future directions in anticoagulant treatment

@en

P2093

Paul A Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

Ximelagatran: direct thrombin inhibitor

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.

Why do patients with atrial fibrillation not receive warfarin?

Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran.

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.

P304

32S-41S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029609344199

http://www.w3.org/2001/XMLSchema#string

P478

15 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19679590

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation